Swiss say more data needed on AstraZeneca jab
Swiss regulators said Wednesday that data submitted by AstraZeneca were not yet sufficient for it to authorise use of the Anglo-Swedish firm's COVID-19 vaccine and "new studies" were needed.
Feb 3, 2021
0
7